Form 4: Allstate CEO Sells Shares Under Pre-Arranged 10b5-1 Plan
Insider Transaction Report
Allstate Corporation's Chairman, President, and CEO, Thomas J. Wilson, reported the sale of 16,807 shares of common stock on December 15, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Thomas J. Wilson, Chairman, President & CEO of Allstate Corp, sold a total of 16,807 shares of common stock on December 15, 2025.
- The sales were executed at weighted average prices ranging from $208.3456 to $210.9611 per share.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted on June 27, 2025.
- Following these sales, Wilson directly holds 128,005.491 shares of common stock.
- Wilson also holds significant indirect beneficial ownership through various GRATs (2023-B, 2024-C, 2025-A, 2020 GRAT Remainder Trust, Remainder GRAT) and a 401(k) Plan, totaling 787,753 shares.
- The filing also details transfers of vested employee stock options to TJW Options LLC series on December 12, 2025, and outlines remaining directly held and unvested options.
Sentiment
Score: 5
Explanation: Neutral. The filing reports routine insider stock sales and option transfers under a pre-arranged 10b5-1 plan, which is a common practice for executives and does not inherently indicate positive or negative sentiment regarding the company's future performance.
Positives
- Sales were conducted under a Rule 10b5-1 trading plan, indicating pre-scheduled transactions rather than reactive selling.
Negatives
- Chairman, President & CEO Thomas J. Wilson sold 16,807 shares of company common stock.
Future Outlook
No specific future outlook or guidance is provided in this insider transaction report.
Industry Context
This Form 4 filing details routine insider transactions and does not provide broader industry context or trends.
Related Party Transactions
- Indirect beneficial ownership through various GRATs (2023-B GRAT, 2024-C GRAT, 2025-A GRAT, 2020 GRAT Remainder Trust, Remainder GRAT).
- Transfers of vested employee options to TJW Options LLC 2022 Series Last Third, TJW Options LLC 2023 Series Middle Third, and TJW Options LLC 2024 Series First Third.
Stakeholder Impact
- Shareholders: The sale of shares by a high-ranking executive could be interpreted in various ways, though sales under a 10b5-1 plan are generally less concerning as they are pre-scheduled. It slightly reduces the executive's direct ownership stake.
Next Steps
- Remaining increments of 2023 stock options will vest on February 16, 2026.
- Remaining increments of 2024 stock options will vest on February 21, 2026, and February 21, 2027.
Key Dates
| Date | Description |
|---|---|
| 2023-02-16 | Grant date for employee stock option award of 157,835 shares. |
| 2024-02-21 | Grant date for employee stock option award of 119,784 shares. |
| 2025-02-17 | Date exercisable for certain employee stock options. |
| 2025-06-27 | Adoption date of Rule 10b5-1 trading plan. |
| 2025-12-12 | Transfer of vested employee options to TJW Options LLC series. |
| 2025-12-15 | Transaction date for common stock sales. |
| 2025-12-17 | Signature date of the reporting person. |
| 2026-02-16 | Vesting date for a remaining increment of a 2023 stock option award. |
| 2026-02-21 | Vesting date for a remaining increment of a 2024 stock option award. |
| 2027-02-21 | Vesting date for a remaining increment of a 2024 stock option award. |
| 2032-02-17 | Expiration date for certain employee stock options. |
| 2033-02-16 | Expiration date for certain employee stock options. |
| 2034-02-21 | Expiration date for certain employee stock options. |
Recommendation
holdThe filing is a routine Form 4 detailing insider stock sales and option transfers under a pre-arranged 10b5-1 plan. Such transactions are common for executives for personal financial planning and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this report. Therefore, a 'hold' recommendation is appropriate as this filing provides no new material information to alter an existing investment thesis.
Keywords
Allstate, ALL, Thomas J. Wilson, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Executive Compensation, Common Stock, Employee Stock Options, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.